| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 2281611
[patent_doc_number] => 04619939
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1986-10-28
[patent_title] => 'Process for reducing intraocular pressure'
[patent_app_type] => 1
[patent_app_number] => 6/729907
[patent_app_country] => US
[patent_app_date] => 1985-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2260
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 160
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/619/04619939.pdf
[firstpage_image] =>[orig_patent_app_number] => 729907
[rel_patent_id] =>[rel_patent_doc_number] =>) 06/729907 | Process for reducing intraocular pressure | May 2, 1985 | Issued |
Array
(
[id] => 2212415
[patent_doc_number] => 04615882
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1986-10-07
[patent_title] => 'Disinfectant solution for contact lens'
[patent_app_type] => 1
[patent_app_number] => 6/729560
[patent_app_country] => US
[patent_app_date] => 1985-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4776
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 180
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/615/04615882.pdf
[firstpage_image] =>[orig_patent_app_number] => 729560
[rel_patent_id] =>[rel_patent_doc_number] =>) 06/729560 | Disinfectant solution for contact lens | May 1, 1985 | Issued |
| 90/000770 | ULTRAPURE HYALURONIC ACID AND THE USE THEREOF | Apr 29, 1985 | Issued |
Array
(
[id] => 2245596
[patent_doc_number] => 04613617
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1986-09-23
[patent_title] => 'Synergistic insecticidal compositions containing dione esters'
[patent_app_type] => 1
[patent_app_number] => 6/724960
[patent_app_country] => US
[patent_app_date] => 1985-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13383
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/613/04613617.pdf
[firstpage_image] =>[orig_patent_app_number] => 724960
[rel_patent_id] =>[rel_patent_doc_number] =>) 06/724960 | Synergistic insecticidal compositions containing dione esters | Apr 22, 1985 | Issued |
Array
(
[id] => 2225135
[patent_doc_number] => 04624957
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1986-11-25
[patent_title] => 'Treatment and prevention of retinal edema with dopaminergic antagonists'
[patent_app_type] => 1
[patent_app_number] => 6/725101
[patent_app_country] => US
[patent_app_date] => 1985-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1512
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/624/04624957.pdf
[firstpage_image] =>[orig_patent_app_number] => 725101
[rel_patent_id] =>[rel_patent_doc_number] =>) 06/725101 | Treatment and prevention of retinal edema with dopaminergic antagonists | Apr 18, 1985 | Issued |
Array
(
[id] => 2281568
[patent_doc_number] => 04619936
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1986-10-28
[patent_title] => 'Pharmaceutical compositions having appetite reducing activity and a process for their preparation'
[patent_app_type] => 1
[patent_app_number] => 6/742466
[patent_app_country] => US
[patent_app_date] => 1985-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2083
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/619/04619936.pdf
[firstpage_image] =>[orig_patent_app_number] => 742466
[rel_patent_id] =>[rel_patent_doc_number] =>) 06/742466 | Pharmaceutical compositions having appetite reducing activity and a process for their preparation | Apr 18, 1985 | Issued |
| 06/724250 | PROCESS FOR LUBRICATING WATER-SOLUBLE VITAMIN POWDERS | Apr 16, 1985 | Abandoned |
| 06/723844 | NASAL COMPOSITIONS CONTAINING VITAMIN B12 | Apr 15, 1985 | Abandoned |
Array
(
[id] => 2423454
[patent_doc_number] => 04780455
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1988-10-25
[patent_title] => 'Lipophilic complexes of pharmacologically active organic compounds'
[patent_app_type] => 1
[patent_app_number] => 6/722735
[patent_app_country] => US
[patent_app_date] => 1985-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3861
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/780/04780455.pdf
[firstpage_image] =>[orig_patent_app_number] => 722735
[rel_patent_id] =>[rel_patent_doc_number] =>) 06/722735 | Lipophilic complexes of pharmacologically active organic compounds | Apr 11, 1985 | Issued |
Array
(
[id] => 2266720
[patent_doc_number] => 04629730
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1986-12-16
[patent_title] => 'Method for treating intraocular hypertension'
[patent_app_type] => 1
[patent_app_number] => 6/722038
[patent_app_country] => US
[patent_app_date] => 1985-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8856
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/629/04629730.pdf
[firstpage_image] =>[orig_patent_app_number] => 722038
[rel_patent_id] =>[rel_patent_doc_number] =>) 06/722038 | Method for treating intraocular hypertension | Apr 10, 1985 | Issued |
Array
(
[id] => 2276749
[patent_doc_number] => 04581376
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1986-04-08
[patent_title] => 'Norepinephrine potentiated compositions and method of use'
[patent_app_type] => 1
[patent_app_number] => 6/722177
[patent_app_country] => US
[patent_app_date] => 1985-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3108
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/581/04581376.pdf
[firstpage_image] =>[orig_patent_app_number] => 722177
[rel_patent_id] =>[rel_patent_doc_number] =>) 06/722177 | Norepinephrine potentiated compositions and method of use | Apr 9, 1985 | Issued |
| 06/720957 | LAMELLAR VESICLES FORMED OF CHOLESTEROL DERIVATIVES | Apr 7, 1985 | Abandoned |
Array
(
[id] => 2329058
[patent_doc_number] => 04634698
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1987-01-06
[patent_title] => 'Antiglaucoma agents'
[patent_app_type] => 1
[patent_app_number] => 6/721015
[patent_app_country] => US
[patent_app_date] => 1985-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6500
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 572
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/634/04634698.pdf
[firstpage_image] =>[orig_patent_app_number] => 721015
[rel_patent_id] =>[rel_patent_doc_number] =>) 06/721015 | Antiglaucoma agents | Apr 7, 1985 | Issued |
Array
(
[id] => 2219526
[patent_doc_number] => 04621085
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1986-11-04
[patent_title] => '2,4,7-triamino-6-phenylpteridine'
[patent_app_type] => 1
[patent_app_number] => 6/719570
[patent_app_country] => US
[patent_app_date] => 1985-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1954
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/621/04621085.pdf
[firstpage_image] =>[orig_patent_app_number] => 719570
[rel_patent_id] =>[rel_patent_doc_number] =>) 06/719570 | 2,4,7-triamino-6-phenylpteridine | Apr 2, 1985 | Issued |
| 06/718876 | LIPID COMPOSITION FOR DELIVERY OF ORALLY ADMINISTERED DRUGS AND OTHER SUBSTANCES | Apr 1, 1985 | Abandoned |
Array
(
[id] => 2362160
[patent_doc_number] => 04665089
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1987-05-12
[patent_title] => 'Process for preventing or reversing cataract formation using protein modification reagents'
[patent_app_type] => 1
[patent_app_number] => 6/714599
[patent_app_country] => US
[patent_app_date] => 1985-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2576
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/665/04665089.pdf
[firstpage_image] =>[orig_patent_app_number] => 714599
[rel_patent_id] =>[rel_patent_doc_number] =>) 06/714599 | Process for preventing or reversing cataract formation using protein modification reagents | Mar 20, 1985 | Issued |
Array
(
[id] => 2346196
[patent_doc_number] => 04649047
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1987-03-10
[patent_title] => 'Ophthalmic treatment by topical administration of cyclosporin'
[patent_app_type] => 1
[patent_app_number] => 6/713701
[patent_app_country] => US
[patent_app_date] => 1985-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 4674
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/649/04649047.pdf
[firstpage_image] =>[orig_patent_app_number] => 713701
[rel_patent_id] =>[rel_patent_doc_number] =>) 06/713701 | Ophthalmic treatment by topical administration of cyclosporin | Mar 18, 1985 | Issued |
| 06/711424 | OPHTHAMIC PREPARATIONS CONTAINING ONE OR MORE RETINOIDS | Mar 12, 1985 | Abandoned |
| 06/711419 | TOPICAL OPHTHALMIC PREPARATIONS | Mar 12, 1985 | Abandoned |
Array
(
[id] => 2361282
[patent_doc_number] => 04657930
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1987-04-14
[patent_title] => 'Mitotic inhibitors preventing posterior lens capsule opacification'
[patent_app_type] => 1
[patent_app_number] => 6/708753
[patent_app_country] => US
[patent_app_date] => 1985-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2543
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/657/04657930.pdf
[firstpage_image] =>[orig_patent_app_number] => 708753
[rel_patent_id] =>[rel_patent_doc_number] =>) 06/708753 | Mitotic inhibitors preventing posterior lens capsule opacification | Mar 5, 1985 | Issued |